Summary

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to MSCI.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.32 for the 2024 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● This company will be of major interest to investors in search of a high dividend stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last few months, analysts have been revising downwards their earnings forecast.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.